Passage Bio, Inc. (PASG)
USD 0.61
(-8.79%)
USD 0.61
(-8.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -78.26 Million | -118.21 Million | -126.87 Million | -80.52 Million | -39.89 Million | -18.56 Million |
| Net Income | -102.06 Million | -136.12 Million | -185.38 Million | -112.23 Million | -45.63 Million | -12.77 Million |
| Depreciation & Amortization | 3.72 Million | 3.67 Million | 1.54 Million | 800 Thousand | 134 Thousand | - |
| Deferred income taxes | 2.79 Million | - | 2.77 Million | 633 Thousand | 9.14 Million | - |
| Stock-based compensation | 10.92 Million | 18.95 Million | 32.69 Million | 14.58 Million | 1.45 Million | - |
| Change in working capital | 5.33 Million | -8.49 Million | 11.42 Million | 14.44 Million | -5.94 Million | -8.52 Million |
| Other non-cash items | 1.02 Million | 3.77 Million | 10.07 Million | 1.25 Million | 952 Thousand | 2.72 Million |
| Investing Cash Flow | 65.23 Million | 25.19 Million | -45.81 Million | -172.1 Million | -1.69 Million | -2.54 Million |
| Investments in PPE | -146 Thousand | -5.27 Million | -25.64 Million | -1.64 Million | -1.69 Million | -2.54 Million |
| Acquisitions | - | 3 Million | 8 Million | 500 Thousand | - | - |
| Investment purchases | -129.43 Million | -157.83 Million | -202.54 Million | -266.05 Million | - | - |
| Sales/Maturities of investments | 194.81 Million | 188.3 Million | 182.37 Million | 95.59 Million | - | - |
| Other Investing Activities | -2.00 | -3 Million | -8 Million | -500 Thousand | -500.00 | -2515.00 |
| Financing Cash Flow | 135 Thousand | -1353.00 | 166.65 Thousand | 228.75 Million | 175.6 Million | 45.97 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 135 Thousand | 304 Thousand | 887 Thousand | 284 Thousand | - | - |
| Common Stock Issuance | 135 Thousand | 433 Thousand | 166.65 Million | 228.26 Million | 175.6 Million | 45.97 Million |
| Other Financing Activities | 135.00 | -1353.00 | 166.65 Thousand | 208 Thousand | -763 Thousand | 45.97 Million |
| Accounts receivables | - | - | - | - | 398 Thousand | 212 Thousand |
| Accounts payables | -2.79 Million | -5.41 Million | 2.2 Million | 4.58 Million | 398 Thousand | 212 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 8.12 Million | -3.07 Million | 9.21 Million | 9.85 Million | -6.73 Million | -8.94 Million |
| Cash at beginning of period | 34.6 Million | 128.96 Million | 135 Million | 158.87 Million | 24.86 Million | - |
| Cash at end of period | 21.7 Million | 34.6 Million | 128.96 Million | 135 Million | 158.87 Million | 24.86 Million |
| Capital Expenditure | -146 Thousand | -5.27 Million | -25.64 Million | -1.64 Million | -1.69 Million | -2.54 Million |
| Effect of forex changes on cash | 1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -12.89 Million | -94.36 Million | -6.03 Million | -23.87 Million | 134.01 Million | 24.86 Million |
| Free Cash Flow | -78.41 Million | -123.48 Million | -152.52 Million | -82.16 Million | -41.58 Million | -21.11 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.99 Million | -16.71 Million | -16.75 Million | -102.06 Million | -27.11 Million | -23.85 Million |
| Depreciation & Amortization | 800 Thousand | 806 Thousand | 807 Thousand | 3.72 Million | 958 Thousand | 978 Thousand |
| Deferred income taxes | - | - | -4.65 Million | 2.79 Million | 11.28 Million | 8.05 Million |
| Stock-based compensation | 1.57 Million | 1.59 Million | 1.57 Million | 10.92 Million | 2.82 Million | 3.74 Million |
| Change in working capital | 339 Thousand | -4.17 Million | -4.28 Million | 5.33 Million | -906 Thousand | 2.3 Million |
| Other non-cash items | 4.38 Million | 2.37 Million | 3.81 Million | 1.02 Million | -6.21 Million | -8.36 Million |
| Investing Cash Flow | 1.04 Million | 25.25 Million | 7.6 Million | 65.23 Million | 22.45 Million | 13.96 Million |
| Investments in PPE | - | - | -13 Thousand | -146 Thousand | -4000.00 | -103 Thousand |
| Acquisitions | - | - | -7613.00 | - | -22.45 Thousand | -14.07 Thousand |
| Investment purchases | -37.01 Million | -13.8 Million | -27.79 Million | -129.43 Million | -28.11 Million | -22.13 Million |
| Sales/Maturities of investments | 38.06 Million | 39.06 Million | 35.4 Million | 194.81 Million | 50.56 Million | 36.2 Million |
| Other Investing Activities | 1048.00 | 25.25 Thousand | 7613.00 | -2.00 | 22.45 Thousand | 14.07 Thousand |
| Financing Cash Flow | 85 Thousand | 8.74 Million | 46 Thousand | 135 Thousand | - | 89 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 135 Thousand | 135 Thousand | - | - |
| Common Stock Issuance | 85 Thousand | 8.74 Million | 46 Thousand | 135 Thousand | - | 89 Thousand |
| Other Financing Activities | 85.00 | 8742.00 | 46.00 | 135.00 | - | 89.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.06 Million | 389 Thousand | -1.47 Million | -2.79 Million | -634 Thousand | 357 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.4 Million | -4.56 Million | -2.81 Million | 8.12 Million | -272 Thousand | 1.94 Million |
| Cash at beginning of period | 36.77 Million | 21.7 Million | 33.57 Million | 34.6 Million | 30.29 Million | 33.37 Million |
| Cash at end of period | 24.77 Million | 36.77 Million | 21.7 Million | 21.7 Million | 33.57 Million | 30.29 Million |
| Capital Expenditure | - | - | -13 Thousand | -146 Thousand | -4000.00 | -103 Thousand |
| Effect of forex changes on cash | - | - | -11.44 Million | 1.00 | - | 11.44 Million |
| Net cash flow / Change in cash | -12 Million | 15.06 Million | -11.87 Million | -12.89 Million | 3.28 Million | -3.08 Million |
| Free Cash Flow | -13.13 Million | -18.92 Million | -19.52 Million | -78.41 Million | -19.16 Million | -17.24 Million |
1600
AMPS
DHANI
DBGF
BFS
0923